The Nasovac S Vaccine contains an active component called the inactivated or weakened influenza viruses. This primarily aims to prevent individuals from contracting the influenza virus. Even if a vaccinated individual still contracts the flu, the vaccine can potentially reduce the severity of symptoms and the duration of the illness. Influenza can be particularly dangerous for certain groups, including the elderly, young children, pregnant women, and individuals with certain chronic health conditions. Vaccinating these populations can help protect them from severe complications and reduce the chances of hospitalisation or death. Increasing the number of vaccinated individuals can reduce the spread of this medication within communities. Some people may be allergic to certain vaccine components, such as eggs or other vaccine ingredients. In such cases, specific precautions may be necessary. If an individual has had a severe allergic reaction to a previous dose of the Nasovac S Vaccine, they may be advised not to receive further doses. Individuals who have a history of Guillain-Barré syndrome may need to consult with a healthcare provider before receiving this medication vaccine, as there has been some association between GBS and this medication. People with kidney disease can receive the Nasovac S Vaccine safely. It is recommended for older adults as they are at a higher risk of developing severe complications from the flu.